CLINICAL TRIALS PROFILE FOR HYDRODIURIL

All Clinical Trials for HYDRODIURIL

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00797862 ↗	Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension	Completed	Novartis	Phase 3	2008-11-01	This study will compare the safety and efficacy of initial combination treatment with aliskiren + amlodipine to sequential add-on treatment strategies with aliskiren or amlodipine in patients with hypertension.
NCT00896389 ↗	Salt Loading and Thiazide Intervention Study	Completed	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 4	2009-10-01	The investigators of this study propose to examine the relationships between STK39 (Serine Threonine Kinase 39) genotypes and responses to salt loading and to thiazide diuretics, hydrochlorothiazide. The investigators hypothesize that STK39 genotypes will be associated with the outcome of both interventions and can contribute to personalized care for hypertension.
NCT00896389 ↗	Salt Loading and Thiazide Intervention Study	Completed	University of Maryland	Phase 4	2009-10-01	The investigators of this study propose to examine the relationships between STK39 (Serine Threonine Kinase 39) genotypes and responses to salt loading and to thiazide diuretics, hydrochlorothiazide. The investigators hypothesize that STK39 genotypes will be associated with the outcome of both interventions and can contribute to personalized care for hypertension.
NCT00896389 ↗	Salt Loading and Thiazide Intervention Study	Completed	University of Maryland, Baltimore	Phase 4	2009-10-01	The investigators of this study propose to examine the relationships between STK39 (Serine Threonine Kinase 39) genotypes and responses to salt loading and to thiazide diuretics, hydrochlorothiazide. The investigators hypothesize that STK39 genotypes will be associated with the outcome of both interventions and can contribute to personalized care for hypertension.
NCT01258764 ↗	Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril	Completed	Scripps Translational Science Institute	N/A	2010-11-01	The purpose of this trial is to evaluate if an objective clinical decision of anti-hypertensive therapy can be made using an N-of-1 (single patient) trial design.

Clinical Trial Conditions for HYDRODIURIL

Condition Name

Condition Name for HYDRODIURIL
Intervention	Trials
Hypertension	5
Chronic Kidney Disease	1
Hypertension Treatment	1
Hypertension, Grade 1	1

Condition MeSH

Condition MeSH for HYDRODIURIL
Intervention	Trials
Hypertension	7
Sleep Apnea Syndromes	1
Renal Insufficiency, Chronic	1
Kidney Diseases	1

Clinical Trial Locations for HYDRODIURIL

Trials by Country

Trials by Country for HYDRODIURIL
Location	Trials
United States	3
South Africa	1
Venezuela	1
France	1
Guatemala	1

Trials by US State

Trials by US State for HYDRODIURIL
Location	Trials
New Mexico	1
California	1
Pennsylvania	1

Clinical Trial Progress for HYDRODIURIL

Clinical Trial Phase

Clinical Trial Phase for HYDRODIURIL
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
N/A	1

Clinical Trial Status

Clinical Trial Status for HYDRODIURIL
Clinical Trial Phase	Trials
Completed	5
Terminated	1
Unknown status	1

Clinical Trial Sponsors for HYDRODIURIL

Sponsor Name

Sponsor Name for HYDRODIURIL
Sponsor	Trials
University of California, San Diego	2
The First Affiliated Hospital of Anhui Medical University	1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	1

Sponsor Type

Sponsor Type for HYDRODIURIL
Sponsor	Trials
Other	15
Industry	2
NIH	1